Compared to Q2 2023, we have decreased our operating expenses by more than $600 million in Q2 2024. This reduction highlights our commitment to operational efficiency and financial discipline.

Analysts estimate EPS of $4.55 vs. $6.46 in Q2 FY 2021. Revenue is expected to grow at a slower rate as global pandemic eases. On July 29, Moderna received a U.S. government order for 66 million ...

Moderna’s financial results for the second quarter of 2024 reveal a mixed bag of outcomes. The company reported total revenue of $241 million, down from $344 million in the same period last year ...

Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue ...

Moderna (MRNA) beats expectations for earnings and sales. Management cuts sales guidance by $0.5-$1.0 billion on concerns about competition for its marketed products and low sales in the EU.

Moderna will announce Q2 2024 earnings this Thursday, 1st August. Moderna stock hit highs of $450 per share in late 2021, but has since seen a decrease ~$120, and a current market cap valuation of ...

Moderna (MRNA) came out with a quarterly loss of $3.33 per share versus the Zacks Consensus Estimate of a loss of $3.47. This compares to loss of $3.62 per share a year ago. These figures are ...

Moderna (MRNA-1.89%) announced its second-quarter results before the market opened on Wednesday. And it easily beat Wall Street's expectations. The vaccine maker reported Q2 revenue of $4.7 ...

Moderna Inc. (NASDAQ:MRNA) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ETCompany ParticipantsStéphane Bancel - Chief Executive OfficerStephen ...